Previous studies demonstrated that FN1 is a potential therapeutic target highly related to tumor invasion in PTC and medullary carcinoma, and it is also one of the markers to distinguish malignant from benign nodules in thyroid cancer [35–37]. Here, FN1 is linked to neoplasm.